TA
PFE icon

TPG Advisors’s Pfizer PFE Stock Holding History

TPG Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$248K Sell
8,684
-186
-2% -$4.95K 0.13% 100
2026
Q2 		$214K Buy
8,870
+393
+5% +$10.3K 0.12% 107
2026
Q1 		$238K Buy
8,477
+67
+0.8% +$1.78K 0.15% 99
2025
Q4 		$209K Buy
+8,410
New +$212K 0.13% 99

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Valley Wealth Managers
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

TPG Advisors's PFE Position: Q3 2026 in Review

TPG Advisors reduced its Pfizer (PFE) stake by 2.1% in Q3 2026, selling an estimated $4.95K and leaving 8,684 shares worth $248K. The position accounts for 0.13% of the portfolio, ranked #100.

TPG Advisors first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 551 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • TPG Advisors held 8,684 shares of Pfizer worth $248K as of Q3 2026.
  • TPG Advisors sold 186 Pfizer shares in Q3 2026, an estimated $4.95K.
  • Pfizer made up 0.13% of TPG Advisors's portfolio in Q3 2026, its #100 holding.
  • TPG Advisors first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 551 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on TPG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.